Cyclotides: a natural combinatorial peptide library or a bioactive sequence player?

References

• (a) Hruby VJ. Peptide science: exploring the use of chemical principles and interdisciplinary collaboration for understanding life processes. J Med Chem 2003;46:4215–31. (b) Subiros-Funosas R, El-Faham A, Albericio F. PyOxP and PyOxB: the Oxyma-based novel family of phosphonium salts. Org Biomol Chem 2010;8:3665–73. (c) Hoyer D, Bartfai T. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach. Chem Biodivers 2012;9:2367–87. (d) Moretto A, Crisma M, Formaggio F, Toniolo C. Building a bridge between peptide chemistry and organic chemistry: intramolecular macrocyclization reactions and supramolecular chemistry with helical peptide substrates. Pept Sci 2010;94:721–32. (e) Mollica A, Pinnen F, Stefanucci A, Costante R. The evolution of peptide synthesis: from early days to small molecular machines. Curr Bioact Comp 2013;9:184–202
   Google Scholar
• Mollica A, Guardiani G, Davis P, et al. Synthesis of stable and potent δ/μ opioid peptides: analogues of H-Tyr-c[d-Cys-Gly-Phe-d-Cys]-OH by ring-closing metathesis. J Med Chem 2007;50:3138–42
   PubMed Web of Science ®Google Scholar
• (a) Gran L. An oxytocic principle found in Oldenlandia affinis DC. Medd Medd Nor Farm Selsk 1970;12:173–80. (b) Gran L. On the effect of a polypeptide isolated from “Kalata-Kalata” (Oldenlandia affinis DC) on the dominated uterus. Acta Pharmacol Toxicol 1973;33:400–8. (c) Gran L. Oxytocic principles of Oldenlandia affinis. Lloydia 1973;36:174–8
   Google Scholar
• (a) Mulvenna JP, Wang C, Craik DJ. CyBase: a database of cyclic protein sequence and structure. Nucleic Acids Res 2007;34:D192–4. (b) Rosengren KJ, Daly NL, Plan MR, et al. Twists, knots, and rings in proteins. Structural definition of the cyclotide framework. J Biol Chem 2003;278:8606–16. (c) Göransson U, Herrmann A, Burman R, et al. The conserved Glu in the cyclotide cycloviolacine O2 has a key structural role. Chem Bio Chem 2009;10:2354–60. (d) Jennings C, West J, Waine C, et al. The conserved glu in the cyclotide cycloviolacin O2 has a key structural role. Proc Natl Acad Sci USA 2001;98:10614–19. (e) Ireland DC, Colgrave ML, Nguyencong P, et al. Discovery and characterization of a linear cyclotide from Viola odorata: implications for the processing of circular proteins. J Mol Biol 2006;357:1522–35
   Google Scholar
• (a) Plan MRR, Saska I, Cagauan AG, Craik DJ. Backbone cyclised peptides from plants show molluscicidal activity against the rice pest Pomacea canaliculata (golden apple snail). J Agric Food Chem 2008;56:5237–41. (b) Gran L, Sandberg F, Sletten K. Oldenlandia affinis (R&S) DC. A plant containing uteroactive peptides used in African traditional medicine. J Ethnopharmacol 2000;70:197–203. (c) Gran L, Sletten K, Skjeldal L. Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties. Chem Biodivers 2008;5:2014–22
   Google Scholar
• (a) Witherup KM, Bogusky MJ, Anderson PS, et al. Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J Nat Prod 1994;57:1619–25. (b) Pranting M, Loov C, Burman R, et al. The cyclotide cycloviolacin O2 from Viola odorata has potent bactericidal activity against Gram-negative bacteria. J Antimicrob Chemother 2010;65:1964–71
   Google Scholar
• Ireland DC, Clark RJ, Daly NL, Craik DJ. Isolation, sequencing, and structure-activity relationships of cyclotides. J Nat Prod 2010;73:1610–22
   PubMed Web of Science ®Google Scholar
• (a) Göransson U, Luijendijk T, Johansson S, et al. Seven novel macrocyclic polypeptides from Viola arvensis. J Nat Prod 1999;62:283–6. (b) Burman R, Gunasekera S, Strömstedt AA, Göransson U. Chemistry and biology of cyclotides: circular plant peptides outside the box. J Nat Prod 2014;77:724–36
   Google Scholar
• Wang CK, Kaas Q, Chiche L, Craik DJ. CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering. Nucleic Acids Res 2008;36:D206–10
   PubMed Web of Science ®Google Scholar
• (a) Mulvenna JP, Wang C, Craik DJ. CyBase: a database of cyclic protein sequence and structure. Nucleic Acids Res 2006;34:D192–4. (b) Chiche L, Heitz A, Gelly JC, et al. Squash inhibitors: from structural motifs to macrocyclic knottins. Curr Protein Pept Sci 2004;5:341–9
   Google Scholar
• Gruber CW, Muttenthaler M, Freissmuth M. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. Curr Pharm Des 2010;16:3071–88
   PubMed Web of Science ®Google Scholar
• (a) Göransson U, Burman R, Gunasekera S, et al. Circular proteins from plants and fungi. J Biol Chem 2012;287:27001–6. (b) Colgrave ML, Poth A, Kaas Q, Craik DJ. A new “era” for cyclotide sequencing. Biopolymers 2010;94:592–601
   Google Scholar
• Nomura T, Quesada AL, Kutchan TM. The new beta-d-glucosidase in terpenoid-isoquinoline alkaloid biosynthesis in Psychotria ipecacuanha. J Biol Chem 2008;283:34650–9
   PubMed Web of Science ®Google Scholar
• Johnson MT, Carpenter EJ, Tian Z, et al. Evaluating methods for isolating total RNA and predicting the success of sequencing phylogenetically diverse plant transcriptomes. PLoS One 2012;7:1–12
   Web of Science ®Google Scholar
• (a) Ireland DC, Colgrave ML, Craik DJ. A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability. Biochem J 2006;400:1–12. (b) Lindholm P, Göransson U, Johansson S, et al. Cyclotides: a novel type of cytotoxic agents. Mol Cancer Ther 2002;1:365–9. (c) Strömstedt A, Ringstad L, Schmidtchen A, Malmsten M. Interaction between amphiphilic peptides and phospholipid membranes. Curr Opin Colloid Interface Sci 2010;15:467–78. (d) Svangård E, Göransson U, Hocaoglu Z, et al. Cytotoxic cyclotides from Viola tricolor. J Nat Prod 2004;67:144–7
   Google Scholar
• Herrmann A, Svangård E, Claeson P, et al. Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2. Cell Mol Life Sci 2006;63:235–45
   PubMed Web of Science ®Google Scholar
• (a) Simonsen SM, Sando L, Rosengren KJ, et al. Alanine scanning mutagenesis of the prototypic cyclotide reveals a cluster of residues essential for bioactivity. J Biol Chem 2008;283:9805–13. (b) Huang YH, Colgrave ML, Daly NL, et al. The biological activity of the prototypic cyclotide kalata B1 is modulated by the formation of multimeric pores. J Biol Chem 2009;284:20699–707
   Google Scholar
• (a) Wang CK, Hu SH, Martin JL, et al. Combined X-ray and NMR analysis of the stability of the cyclotide cystine knot fold that underpins its insecticidal activity and potential use as a drug scaffold. J Biol Chem 2009;284:10672–83. (b) Nguyen GK, Zhang S, Nguyen NT, et al. Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family. J Biol Chem 2011;286:24275–87
   Google Scholar
• Cheneval O, Schroeder CI, Durek T, et al. Fmoc-based synthesis of disulfide-rich cyclic peptides. J Org Chem 2014;79:5538–44
   PubMed Web of Science ®Google Scholar
• Koehbach J, O’Brien M, Muttenthaler M, et al. Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design. Proc Natl Acad Sci USA 2013;110:21183–8
   PubMed Web of Science ®Google Scholar
• Maggi M. Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors. J Clin Endocrinol Metab 1990;70:1142–54
   PubMed Web of Science ®Google Scholar
• Chan WY, Wo NC, Cheng LL, Manning M. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor. J Pharmacol Exp Ther 1996;277:999–1003
   PubMed Web of Science ®Google Scholar
• Manning M, Misicka A, Olma A, et al. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol 2012;24:609–28
   PubMed Web of Science ®Google Scholar
• (a) Chini B, Mouillac B, Balestre MN, et al. Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett 1996;397:201–6. (b) Koehbach J, Stockner T, Bergmayr C, et al. Insights into the molecular evolution of oxytocin receptor ligand binding. Biochem Soc Trans 2013;41:197–204. (c) Zingg HH, Laporte SA. The oxytocin receptor. Trends Endocrinol Metab 2003;14:222–7
   Google Scholar
• Gruber CW, Koehbach J, Muttenthaler M. Exploring bioactive peptides from natural sources for oxytocin and vasopressin drug discovery. Future Med Chem 2012;4:1791–8
   PubMed Web of Science ®Google Scholar
• Wong CT, Rowlands DK, Wong CH, et al. Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment. Angew Chem Int Ed 2012;51:5620–4
   PubMed Web of Science ®Google Scholar
• Eliasen R, Daly NL, Wulff BS, et al. Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1. J Biol Chem 2012;287:40493–501
   PubMed Web of Science ®Google Scholar
• Gunasekera S, Foley FM, Clark RJ, et al. Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides. J Med Chem 2008;51:7697–704
   PubMed Web of Science ®Google Scholar
• Chan LY, Gunasekera S, Henriques ST, et al. Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. Blood 2011;118:6709–17
   PubMed Web of Science ®Google Scholar
• Aboye TL, Ha H, Majumder S, et al. Design of a novel cyclotide based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity. J Med Chem 2012;55:10729–34
   PubMed Web of Science ®Google Scholar
• Thongyoo P, Bonomelli C, Leatherbarrow RJ, Tate EW. Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold. J Med Chem 2009;52:6197–200
   PubMed Web of Science ®Google Scholar
• (a) Craik DJ. Cyclotides as a basis for drug design. Exp Opin Drug Discov 2012;7:179–94. (b) Colgrave ML, Craik DJ. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry 2004;43:5965–75
   Google Scholar
• Ji Y. In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide. J Am Chem Soc 2013;135:11623–33
   PubMed Web of Science ®Google Scholar
• (a) Craik DJ. Chemistry. Seamless proteins tie up their loose ends. Science 2006;311:1563–4. (b) Gilon C. Backbone cyclization: a new method for conferring conformational constraint on peptides. Biopolymers 1991;31:745–50. (c) Smith AB. Cyclotides: a patent review. Expert Opin Ther Pat 2011;21:1657–72
   Google Scholar
• Wannamethee SG, Shaper AG, Durrington PN, Perry IJ. Hypertension, serum insulin, obesity, and the metabolic syndrome. J Hum Hypertens 1998;12:735–41
   PubMed Web of Science ®Google Scholar
• (a) Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science 1992;257:1248–51. (b) Chhajlani V, Wikberg JE. Molecular cloning and expression of the human melanocyte-stimulating hormone receptor cDNA. FEBS Lett 1992;309:417–20. (c) Gantz I, Konda Y, Tashiro T, et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993;268:8246–50. (d) Gantz I, Miwa H, Konda Y, et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993;268:15174–9. (e) Chhajlani V, Muceniece R, Wikberg JE. Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 1993;195:866–73
   Google Scholar
• He S, Ye Z, Dobbelaar PH, et al. Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity. Bioorg Med Chem Lett 2010;20:6524–65
   PubMed Web of Science ®Google Scholar
• Emmerson PJ, Fisher MJ, Yan LZ, Mayer JP. Melanocortin-4 receptor agonists for the treatment of obesity. Curr Top Med Chem 2007;7:1121–30
   PubMed Web of Science ®Google Scholar